New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 24, 2014
11:14 EDTCHTP, PRAN, ISIS, ARUN, QLIKOptions with decreasing implied volatility: CHTP PRAN ISIS ARUN QLIK
News For CHTP;PRAN;ISIS;ARUN;QLIK From The Last 14 Days
Check below for free stories on CHTP;PRAN;ISIS;ARUN;QLIK the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
July 25, 2014
11:08 EDTQLIKOptions with decreasing implied volatility
Options with decreasing implied volatility: INO PBYI MLNX DECK INFN CMG QLIK LKX ANGI NFLX
09:25 EDTQLIKOn The Fly: Pre-market Movers
Subscribe for More Information
July 24, 2014
18:45 EDTQLIKOn The Fly: After Hours Movers
Subscribe for More Information
16:22 EDTQLIKQlik Technologies sees FY14 EPS 23c-27c, consensus 25c
Subscribe for More Information
16:21 EDTQLIKQlik Technologies sees Q3 EPS (2c)-1c
Subscribe for More Information
16:20 EDTQLIKQlik Technologies reports Q2 EPS 2c, consensus (3c)
Subscribe for More Information
July 21, 2014
10:02 EDTQLIKOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:11 EDTQLIKQlik Technologies risk/reward favorable, says Morgan Stanley
Morgan Stanley said Qlik expectations are low and risk/reward is favorable. The firm believes the QlikView Next release will lead to improved product positioning and sales execution and creates opportunities with business users.
05:28 EDTQLIKQlik Technologies upgraded to Overweight from Equal Weight at Barclays
Barclays upgraded Qlik Technologies to Overweight citing an attractive valuation and the upcoming release of QV.Next, which the firm believes could drive meaningful upside. It keeps a $31 price target for shares.
July 18, 2014
10:03 EDTQLIKOn The Fly: Analyst Initiation Summary
Subscribe for More Information
July 17, 2014
19:22 EDTQLIKQlik Technologies initiated with a Market Perform at BMO Capital
Subscribe for More Information
16:27 EDTPRANPrana updates Alzheimer disease development program
Prana Biotechnology has provided an update on its clinical development program for Alzheimer's disease. In Professor Colin Masters' July presentation, which includes data from Prana's phase 2 IMAGINE and EURO trials, he noted that the starting amyloid burden level in the PBT2 treated participant group had an important bearing on the decrease of amyloid over time in that participant, whereas there was no such correlation in the placebo group. Separately, Prana has confirmed the top line finding that there is a very promising trend towards the preservation of brain volume in PBT2 treated patients compared to placebo patients.
11:00 EDTPRANHigh option volume stocks
High option volume stocks: OMC FXC TSEM JRJC MAT MTG PRAN SEAS BURL
07:10 EDTISISIsis Pharmaceuticals begins Phase 2 study of candidate for high lipoprotein(a)
Subscribe for More Information
July 16, 2014
17:22 EDTARUNAruba Networks initiated with a Neutral at Buckingham
Subscribe for More Information
10:00 EDTQLIKOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: American Airlines (AAL) initiated with an Overweight at Atlantic Equities... Apple (AAPL) initiated with a Buy at Citigroup... Basic Energy (BAS) initiated with a Neutral at RW Baird... Brookdale Senior Living (BKD) initiated with a Buy at Goldman... CA Technologies (CA) initiated with a Market Perform at FBR Capital... Dresser-Rand (DRC) initiated with a Neutral at RW Baird... Fortinet (FTNT) initiated with a Neutral at Goldman... Frank's International (FI) initiated with a Hold at Jefferies... Home Bancorp (HBCP) initiated with an Outperform at Fig Partners... Key Energy (KEG) initiated with an Outperform at RW Baird... McDermott (MDR) initiated with a Neutral at Tigress Financial... ORBCOMM (ORBC) initiated with a Neutral at Macquarie... Oil States (OIS) initiated with an Outperform at RW Baird... PBF Energy (PBF) initiated with an Equal Weight at Barclays... Palo Alto (PANW) assumed with a Conviction Buy at Goldman... Proofpoint (PFPT) initiated with a Buy at Goldman... Qlik Technologies (QLIK) initiated with a Market Perform at FBR Capital... Radius Health (RDUS) initiated with a Buy at Canaccord... Seventy Seven Energy (SSE) initiated with a Hold at Jefferies... Superior Energy (SPN) initiated with an Outperform at RW Baird... Tandem Diabetes (TNDM) initiated with an Outperform at William Blair... Trecora Resources (TREC) initiated with a Buy at B. Riley... Ultragenyx (RARE) initiated with an Outperform at RW Baird... United Natural Foods (UNFI) initiated with an Outperform at Oppenheimer... Viper Energy (VNOM) initiated with a Market Perform at Northland... Whiting Petroleum (WLL) initiated with a Buy at Tigress Financial.
07:55 EDTQLIKQlik Technologies initiated with a Market Perform at FBR Capital
Subscribe for More Information
07:14 EDTISISIsis Pharmaceuticals earns $1M milestone payment from GlaxoSmithKline
Isis Pharmaceuticals (ISIS) has earned a $1M milestone payment from GlaxoSmithKline (GSK) related to the advancement of the Phase 2/3 study of ISIS-TTRRx in patients with familial amyloid polyneuropathy. ISIS-TTRRx is an antisense drug in development with GSK for the treatment of transthyretin amyloidosis, a severe and rare genetic disease characterized by progressive dysfunction of peripheral nerve and/or heart tissues. Including this milestone payment, Isis has generated $27M in upfront and milestone payments for advancing ISIS-TTRRx. If GSK elects to exercise its option to exclusively license the ISIS-TTRRx program, Isis is eligible to receive a license fee, regulatory and sales milestone payments and double-digit royalties on sales of ISIS-TTRRx.
July 14, 2014
10:00 EDTARUNOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:05 EDTARUNAruba Networks upgraded to Outperform from Neutral at Macquarie
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use